{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:26:07Z","timestamp":1767072367085,"version":"3.48.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Institutional Research Grant of the Second Affiliated Hospital of Nanchang University","award":["2023efyA03"],"award-info":[{"award-number":["2023efyA03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05373-5","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:15:34Z","timestamp":1764317734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of neutrophil-to-lymphocyte ratio with the risk of kidney failure in critically ill patients with heart failure: a cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Ning","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningpeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"5373_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","volume":"35","author":"K Damman","year":"2014","unstructured":"Damman K, Valente MAE, Voors AA, O\u2019Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014;35:455\u201369. https:\/\/doi.org\/10.1093\/eurheartj\/eht386.","journal-title":"Eur Heart J"},{"key":"5373_CR2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/biomedicines12050981","volume":"12","author":"G Bonacchi","year":"2024","unstructured":"Bonacchi G, Rossi VA, Garofalo M, Mollace R, Uccello G, Pieragnoli P, et al. Pathophysiological link and treatment implication of heart failure and preserved ejection fraction in patients with chronic kidney disease. Biomedicines. 2024;12:981. https:\/\/doi.org\/10.3390\/biomedicines12050981.","journal-title":"Biomedicines"},{"key":"5373_CR3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2215\/CJN.14180920","volume":"16","author":"D Banerjee","year":"2021","unstructured":"Banerjee D, Rosano G, Herzog CA. Management of heart failure patient with CKD. Clin J Am Soc Nephrol. 2021;16:1131\u20139. https:\/\/doi.org\/10.2215\/CJN.14180920.","journal-title":"Clin J Am Soc Nephrol"},{"key":"5373_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032988","volume":"24","author":"M Szlagor","year":"2023","unstructured":"Szlagor M, Dybiec J, M\u0142ynarska E, Rysz J, Franczyk B. Chronic kidney disease as a comorbidity in heart failure. Int J Mol Sci. 2023;24:2988. https:\/\/doi.org\/10.3390\/ijms24032988.","journal-title":"Int J Mol Sci"},{"key":"5373_CR5","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","volume":"75","author":"SP Murphy","year":"2020","unstructured":"Murphy SP, Kakkar R, McCarthy CP, Januzzi JL. Inflammation in heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75:1324\u201340. https:\/\/doi.org\/10.1016\/j.jacc.2020.01.014.","journal-title":"J Am Coll Cardiol"},{"key":"5373_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000368940","volume":"39","author":"OM Akchurin","year":"2015","unstructured":"Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39:84\u201392. https:\/\/doi.org\/10.1159\/000368940.","journal-title":"Blood Purif"},{"key":"5373_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/cphy.c120028","volume":"3","author":"JD Imig","year":"2013","unstructured":"Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol. 2013;3:957\u201376. https:\/\/doi.org\/10.1002\/cphy.c120028.","journal-title":"Compr Physiol"},{"key":"5373_CR8","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00467-007-0524-0","volume":"22","author":"AB Fogo","year":"2007","unstructured":"Fogo AB. Mechanisms of progression of chronic kidney disease. Pediatr Nephrol. 2007;22:2011\u201322. https:\/\/doi.org\/10.1007\/s00467-007-0524-0.","journal-title":"Pediatr Nephrol"},{"key":"5373_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MAJ.0000000000000501","volume":"350","author":"Y Tang","year":"2015","unstructured":"Tang Y, Zhang F, Huang L, Yuan Q, Qin J, Li B, et al. The protective mechanism of fluorofenidone in renal interstitial inflammation and fibrosis. Am J Med Sci. 2015;350:195\u2013203. https:\/\/doi.org\/10.1097\/MAJ.0000000000000501.","journal-title":"Am J Med Sci"},{"key":"5373_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/0886022X.2019.1595645","volume":"41","author":"R Yoshitomi","year":"2019","unstructured":"Yoshitomi R, Nakayama M, Sakoh T, Fukui A, Katafuchi E, Seki M, et al. High neutrophil\/lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease. Ren Fail. 2019;41:238\u201343. https:\/\/doi.org\/10.1080\/0886022X.2019.1595645.","journal-title":"Ren Fail"},{"key":"5373_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12967-019-1808-4","volume":"17","author":"Q Yuan","year":"2019","unstructured":"Yuan Q, Wang J, Peng Z, Zhou Q, Xiao X, Xie Y, et al. Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). J Transl Med. 2019;17:86. https:\/\/doi.org\/10.1186\/s12967-019-1808-4.","journal-title":"J Transl Med"},{"key":"5373_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s40001-024-01850-3","volume":"29","author":"J Luo","year":"2024","unstructured":"Luo J, Zhou Y, Song Y, Wang D, Li M, Du X, et al. Association between the neutrophil-to-lymphocyte ratio and in-hospital mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit. Eur J Med Res. 2024;29:260. https:\/\/doi.org\/10.1186\/s40001-024-01850-3.","journal-title":"Eur J Med Res"},{"key":"5373_CR13","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1002\/ehf2.13424","volume":"8","author":"FM Curran","year":"2021","unstructured":"Curran FM, Bhalraam U, Mohan M, Singh JS, Anker SD, Dickstein K, et al. Neutrophil-to-lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection fraction. ESC Heart Fail. 2021;8:3168\u201379. https:\/\/doi.org\/10.1002\/ehf2.13424.","journal-title":"ESC Heart Fail"},{"key":"5373_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026326","volume":"12","author":"S Tamaki","year":"2023","unstructured":"Tamaki S, Nagai Y, Shutta R, Masuda D, Yamashita S, Seo M, et al. Combination of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of cardiac death in patients with acute decompensated heart failure with preserved left ventricular ejection fraction: a multicenter study. J Am Heart Assoc. 2023;12:e026326. https:\/\/doi.org\/10.1161\/JAHA.122.026326.","journal-title":"J Am Heart Assoc"},{"issue":"100","key":"5373_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"2021","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO. clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;2021(100):S1-276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021.","journal-title":"Kidney Int"},{"issue":"105","key":"5373_CR16","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"2024","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO. clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;2024(105):S117-314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"key":"5373_CR17","doi-asserted-by":"publisher","unstructured":"Po S, R U, P S, S M. Predictors in adolescence of ESRD in middle-aged men. Am J Kidney Dis. 2014;64. https:\/\/doi.org\/10.1053\/j.ajkd.2014.06.019.","DOI":"10.1053\/j.ajkd.2014.06.019"},{"key":"5373_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11255-018-1994-7","volume":"51","author":"O Altunoren","year":"2019","unstructured":"Altunoren O, Akkus G, Sezal DT, Ciftcioglu M, Guzel FB, Isiktas S, et al. Does neutrophyl to lymphocyte ratio really predict chronic kidney disease progression? Int Urol Nephrol. 2019;51:129\u201337. https:\/\/doi.org\/10.1007\/s11255-018-1994-7.","journal-title":"Int Urol Nephrol"},{"key":"5373_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01933-x","volume":"9","author":"H Wang","year":"2024","unstructured":"Wang H, Kim SJ, Lei Y, Wang S, Wang H, Huang H, et al. Neutrophil extracellular traps in homeostasis and disease. Signal Transduct Target Ther. 2024;9:235. https:\/\/doi.org\/10.1038\/s41392-024-01933-x.","journal-title":"Signal Transduct Target Ther"},{"key":"5373_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.910908","volume":"12","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Xu Z, Liu Z. Impact of neutrophil extracellular traps on thrombosis formation: new findings and future perspective. Front Cell Infect Microbiol. 2022;12:910908. https:\/\/doi.org\/10.3389\/fcimb.2022.910908.","journal-title":"Front Cell Infect Microbiol"},{"key":"5373_CR21","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/ckj\/sfad051","volume":"16","author":"G Valera","year":"2023","unstructured":"Valera G, Figuer A, Caro J, Yuste C, Morales E, Cepri\u00e1n N, et al. Plasma glycocalyx pattern: a mirror of endothelial damage in chronic kidney disease. Clin Kidney J. 2023;16:1278\u201387. https:\/\/doi.org\/10.1093\/ckj\/sfad051.","journal-title":"Clin Kidney J"},{"key":"5373_CR22","doi-asserted-by":"publisher","first-page":"1251876","DOI":"10.3389\/fimmu.2023.1251876","volume":"14","author":"S Yung","year":"2023","unstructured":"Yung S, Chan TM. Endothelial cell activation and glycocalyx shedding - potential as biomarkers in patients with lupus nephritis. Front Immunol. 2023;14:1251876. https:\/\/doi.org\/10.3389\/fimmu.2023.1251876.","journal-title":"Front Immunol"},{"key":"5373_CR23","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCRESAHA.123.321752","volume":"132","author":"CCFMJ Baaten","year":"2023","unstructured":"Baaten CCFMJ, Vondenhoff S, Noels H. Endothelial cell dysfunction and increased cardiovascular risk in patients with chronic kidney disease. Circ Res. 2023;132:970\u201392. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.321752.","journal-title":"Circ Res"},{"key":"5373_CR24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.cardfail.2012.10.010","volume":"18","author":"EA Ross","year":"2012","unstructured":"Ross EA. Congestive renal failure: the pathophysiology and treatment of renal venous hypertension. J Card Fail. 2012;18:930\u20138. https:\/\/doi.org\/10.1016\/j.cardfail.2012.10.010.","journal-title":"J Card Fail"},{"key":"5373_CR25","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1161\/hc4101.096153","volume":"104","author":"AC Schoolwerth","year":"2001","unstructured":"Schoolwerth AC, Sica DA, Ballermann BJ, Wilcox CS. Renal considerations in angiotensin converting enzyme inhibitor therapy. Circulation. 2001;104:1985\u201391. https:\/\/doi.org\/10.1161\/hc4101.096153.","journal-title":"Circulation"},{"key":"5373_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/archinte.160.5.685","volume":"160","author":"GL Bakris","year":"2000","unstructured":"Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med. 2000;160:685\u201393. https:\/\/doi.org\/10.1001\/archinte.160.5.685.","journal-title":"Arch Intern Med"},{"key":"5373_CR27","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","volume":"96","author":"S Peerapornratana","year":"2019","unstructured":"Peerapornratana S, Manrique-Caballero CL, G\u00f3mez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96:1083. https:\/\/doi.org\/10.1016\/j.kint.2019.05.026.","journal-title":"Kidney Int"},{"key":"5373_CR28","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.ekir.2023.08.031","volume":"8","author":"RE Campbell","year":"2023","unstructured":"Campbell RE, Chen CH, Edelstein CL. Overview of antibiotic-induced nephrotoxicity. Kidney Int Rep. 2023;8:2211\u201325. https:\/\/doi.org\/10.1016\/j.ekir.2023.08.031.","journal-title":"Kidney Int Rep"},{"key":"5373_CR29","first-page":"687","volume":"100","author":"MG Mercado","year":"2019","unstructured":"Mercado MG, Smith DK, Guard EL. Acute kidney injury: diagnosis and management. Am Fam Physician. 2019;100:687\u201394.","journal-title":"Am Fam Physician"},{"key":"5373_CR30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4093\/dmj.2023.0201","volume":"48","author":"M-H Chuang","year":"2024","unstructured":"Chuang M-H, Tang Y-S, Chen J-Y, Pan H-C, Liao H-W, Chu W-K, et al. Abrupt decline in estimated glomerular filtration rate after initiating sodium-glucose cotransporter 2 inhibitors predicts clinical outcomes: a systematic review and meta-analysis. Diabetes Metab J. 2024;48:242\u201352. https:\/\/doi.org\/10.4093\/dmj.2023.0201.","journal-title":"Diabetes Metab J"},{"key":"5373_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1404615","author":"J Xu","year":"2024","unstructured":"Xu J, Zeng Q, Li S, Su Q, Fan H. Inflammation mechanism and research progress of COPD. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1404615.","journal-title":"Front Immunol"},{"key":"5373_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19124090","volume":"19","author":"S Ronchetti","year":"2018","unstructured":"Ronchetti S, Ricci E, Migliorati G, Gentili M, Riccardi C. How glucocorticoids affect the neutrophil life. Int J Mol Sci. 2018;19:4090. https:\/\/doi.org\/10.3390\/ijms19124090.","journal-title":"Int J Mol Sci"},{"key":"5373_CR33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.pmedr.2016.08.009","volume":"4","author":"T Higuchi","year":"2016","unstructured":"Higuchi T, Omata F, Tsuchihashi K, Higashioka K, Koyamada R, Okada S. Current cigarette smoking is a reversible cause of elevated white blood cell count: cross-sectional and longitudinal studies. Prev Med Rep. 2016;4:417\u201322. https:\/\/doi.org\/10.1016\/j.pmedr.2016.08.009.","journal-title":"Prev Med Rep"},{"issue":"5","key":"5373_CR34","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/ATVBAHA.118.312338","volume":"39","author":"KM Pedersen","year":"2019","unstructured":"Pedersen KM, \u00c7olak Y, Ellervik C, Hasselbalch HC, Bojesen SE, Nordestgaard BG. Smoking and increased white and red blood cells. Arterioscler Thromb Vasc Biol. 2019;39(5):965\u201377. https:\/\/doi.org\/10.1161\/ATVBAHA.118.312338.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5373_CR35","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2147\/COPD.S452444","volume":"19","author":"C Cai","year":"2024","unstructured":"Cai C, Zeng W, Wang H, Ren S. Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and monocyte-to-lymphocyte ratio (MLR) as biomarkers in diagnosis evaluation of acute exacerbation of chronic obstructive pulmonary disease: a retrospective, observational study. Int J Chron Obstruct Pulmon Dis. 2024;19:933\u201343. https:\/\/doi.org\/10.2147\/COPD.S452444.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"5373_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12931-020-1312-7","volume":"21","author":"EL Axson","year":"2020","unstructured":"Axson EL, Ragutheeswaran K, Sundaram V, Bloom CI, Bottle A, Cowie MR, et al. Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis. Respir Res. 2020;21:54. https:\/\/doi.org\/10.1186\/s12931-020-1312-7.","journal-title":"Respir Res"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05373-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05373-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05373-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:22:54Z","timestamp":1767072174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-025-05373-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5373"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05373-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study used data from MIMIC-IV, which was accessed under certification (No. 12853279) with IRB approval and waived informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"901"}}